Namodenoson is a Selective A3AR Agonist for Hepatocellular Carcinoma Research
Adenosine receptors (ARs) comprise a group of G protein-coupled receptors (GPCR) which mediate the physiological actions of adenosine. To date, four AR subtypes (adenosine A1, A2A, A2B and A3 receptors)…